Bruce is an experienced and accomplished General Manager and Company Director with several decades of success in the global Biopharmaceutical industry.
Bruce is currently a Director of Medicines Australia Limited, Rare Cancers Australia and Australian Genomic Cancer Medicines Centre Limited.
Prior to this Bruce served as Managing Director of the Janssen Pharmaceutical Companies of Johnson & Johnson as part of a 37 year career in various roles at J&J.